These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 130137)

  • 21. Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapy.
    Steinberg AD; Gelfand MC; Hardin JA; Lowenthal DT
    Arthritis Rheum; 1975; 18(1):9-14. PubMed ID: 1115749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism of vasoactive amines in NZB-W glomerulonephritis. I. Beneficial effect of methysergide.
    Chused TM; Tarpley TM; Steinberg AD
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):281-3. PubMed ID: 4272421
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental approach to the pathogenesis of systemic lupus erythematosus].
    Lambert PH; Creighton D; Goodman R; Bankhurst A; Mischer PA
    J Urol Nephrol (Paris); 1972 Dec; 78(12):973-80. PubMed ID: 4350279
    [No Abstract]   [Full Text] [Related]  

  • 24. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids.
    al-Balaghi S; Möller E; Möller G; Abedi-Valugerdi M
    Eur J Immunol; 1996 Jul; 26(7):1519-26. PubMed ID: 8766555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus.
    Croker BP; del Villano BC; Jensen FC; Lerner RA; Dixon FJ
    J Exp Med; 1974 Oct; 140(4):1028-48. PubMed ID: 4372290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies.
    Hahn BH; Ebling FM
    J Clin Invest; 1983 Jun; 71(6):1728-36. PubMed ID: 6223048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated appearance of neoplasms in female NZB/NZW mice treated with high-dose cyclophosphamide.
    Walker SE; Anver MR
    Arthritis Rheum; 1979 Dec; 22(12):1338-43. PubMed ID: 391238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
    Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE
    Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice.
    Prickett JD; Robinson DR; Steinberg AD
    J Clin Invest; 1981 Aug; 68(2):556-9. PubMed ID: 7263863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic studies on the skin lupus band test in New Zealand mice.
    Furukawa F; Maruyama N; Yoshida H; Hamashima Y; Hirose S; Shirai T
    Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclophosphamide on glomerular permeability and localization of immunoreactants in NZB/NZW mice.
    Czechner OI; Cavallo T
    Clin Exp Immunol; 1982 Apr; 48(1):79-84. PubMed ID: 6211318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB X NZW) mice. I. Long-term treatment with azathioprine and ifosfamide.
    Mitrou PS; Fischer M; Mitrou G; Röttger P; Holtz G
    Arzneimittelforschung; 1979; 29(3):483-8. PubMed ID: 314806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulation in New Zealand mice. I. Failure of the transfer of syngeneic spleen or thymus cells to influence the natural disease in New Zealand mice.
    Hoffman AA; Harbeck RJ
    Arthritis Rheum; 1979 Apr; 22(4):412-8. PubMed ID: 154894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice.
    Hirose S; Tokushige K; Kinoshita K; Nozawa S; Saito J; Nishimura H; Shirai T
    Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of nzb/nzw disease with total lymphoid irradiation.
    Kotzin BL; Strober S
    J Exp Med; 1979 Aug; 150(2):371-8. PubMed ID: 313431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
    Song YW; Tsao BP; Hahn BH
    J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice.
    Yoshiki T; Mellors RC; Strand M; August JT
    J Exp Med; 1974 Oct; 140(4):1011-27. PubMed ID: 4279268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
    Dong L; Ito S; Ishii KJ; Klinman DM
    Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective suppression of autoantibody responses in NZB/NZW mice treated with long-term cyclophosphamide.
    Walker SE; Bole GG
    Arthritis Rheum; 1975; 18(3):265-72. PubMed ID: 1095022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.